133 related articles for article (PubMed ID: 27687592)
1. Correlation of neuroendocrine features with prognosis of non-small cell lung cancer.
Feng J; Sheng H; Zhu C; Qian X; Wan D; Su D; Chen X; Zhu L
Oncotarget; 2016 Nov; 7(44):71727-71736. PubMed ID: 27687592
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
3. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
6. [Research on the relationship between non-small cell lung cancer with neuroendocrine differentiation and the biological characteristics and prognosis].
Zhang J; Zheng K; Guo Y; Zhang P; Zhan Z
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):873-6. PubMed ID: 20840816
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E
Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine differentiation is not a malignant index of non-small cell lung cancer].
Dai L; Sun Y; Li X; Chen K
Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):646-52. PubMed ID: 21859545
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
[TBL] [Abstract][Full Text] [Related]
10. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
Linnoila RI; Piantadosi S; Ruckdeschel JC
Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
[TBL] [Abstract][Full Text] [Related]
11. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications.
Segawa Y; Takata S; Fujii M; Oze I; Fujiwara Y; Kato Y; Ogino A; Komori E; Sawada S; Yamashita M; Nishimura R; Teramoto N; Takashima S
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1055-9. PubMed ID: 19152002
[TBL] [Abstract][Full Text] [Related]
13. Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human non-small cell lung cancer.
Liu Q; Su Y; Jiang GC; Zhou ZL; Liu BC; Bu L; Yang F; Qiao F; Wang J
Chin Med J (Engl); 2013 Aug; 126(16):3006-12. PubMed ID: 23981602
[TBL] [Abstract][Full Text] [Related]
14. High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer.
Qian Z; Qingshan C; Chun J; Huijun Z; Feng L; Qiang W; Qiang X; Min Z
Am J Clin Pathol; 2014 Feb; 141(2):226-33. PubMed ID: 24436270
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
16. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine markers in non-small cell lung cancer.
Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
[TBL] [Abstract][Full Text] [Related]
19. High expression of Cullin1 indicates poor prognosis for NSCLC patients.
Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J
Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980
[TBL] [Abstract][Full Text] [Related]
20. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
